×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EVGN – evogene ltd. - ordinary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EVGN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
02:03 am
evgn
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/12
02:02 am
evgn
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/4
02:08 am
evgn
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Neutral
Report
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/26
03:06 am
evgn
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/22
02:13 am
evgn
Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities [Yahoo! Finance]
Neutral
Report
Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities [Yahoo! Finance]
11/21
07:30 am
evgn
Evogene Reports Third Quarter 2024 Financial Results
Medium
Report
Evogene Reports Third Quarter 2024 Financial Results
11/19
07:06 am
evgn
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results [Yahoo! Finance]
Medium
Report
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results [Yahoo! Finance]
11/19
07:00 am
evgn
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
Low
Report
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
Date
Time
Symbol
Company Name
Action
%Chg
3/7/2024
07:00 am
evgn
evogene ltd. - ordinary shares
BEAT
Report
3.2%
evogene ltd. - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/27
04:01 pm
evgn
Form 6-K Evogene Ltd. For: Nov 27
Medium
Report
Form 6-K Evogene Ltd. For: Nov 27
11/21
07:31 am
evgn
Form 6-K Evogene Ltd. For: Nov 21
Medium
Report
Form 6-K Evogene Ltd. For: Nov 21
10/15
06:53 am
evgn
Form SC 13G/A Evogene Ltd. Filed by: SILVERARC CAPITAL MANAGEMENT, LLC
Low
Report
Form SC 13G/A Evogene Ltd. Filed by: SILVERARC CAPITAL MANAGEMENT, LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/25
Form 6-K Evogene Ltd. For: Mar 25
17.4%
4/27 Form 20-F Evogene Ltd. For: Dec 31 11.3%
5/7 Evogene Financial Results for the First Quarter of 2019 3.9%
8/9 Evogene (EVGN) Investor Presentation - Slideshow [Seeking Alpha] 3.5%
5/21 Evofuel to Participate in the 2019 International Castor Oil Association - ICOA Conference 2.9%
7/10 Lavie Bio Announces Positive 2nd Year Field Results in Its Bio-stimulant Program for Wheat 2.6%
2/12 Evogene Financial Results for the Fourth Quarter and Full Year of 2019 Earnings Announcement Schedule 2.1%
7/15 Evogene to Present at Jefferies 2019 Industrials Conference 2.0%
5/14 Form 6-K Evogene Ltd. For: May 14 1.7%
1/28 Form 6-K Evogene Ltd. For: Jan 28 1.3%
4/27 Form 20-F Evogene Ltd. For: Dec 31 11.3%
5/7 Evogene Financial Results for the First Quarter of 2019 3.9%
8/9 Evogene (EVGN) Investor Presentation - Slideshow [Seeking Alpha] 3.5%
5/21 Evofuel to Participate in the 2019 International Castor Oil Association - ICOA Conference 2.9%
7/10 Lavie Bio Announces Positive 2nd Year Field Results in Its Bio-stimulant Program for Wheat 2.6%
2/12 Evogene Financial Results for the Fourth Quarter and Full Year of 2019 Earnings Announcement Schedule 2.1%
7/15 Evogene to Present at Jefferies 2019 Industrials Conference 2.0%
5/14 Form 6-K Evogene Ltd. For: May 14 1.7%
1/28 Form 6-K Evogene Ltd. For: Jan 28 1.3%
TOP News Decliners
1/13
Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127 for its Immuno-Oncology Program
-6.6%
7/31 Q2/2019 6/30/2019 EPS -0.160 ZacksConsensus N/A ActVsEst N/A - N/A -5.4%
3/4 Q4/2019 12/31/2019 EPS -0.240 ZacksConsensus N/A ActVsEst N/A - N/A -5.2%
7/16 Evogene Amends its Collaboration Agreement With Bayer to Include Genome Editing Targets -5.1%
2/11 Form SC 13G/A Evogene Ltd. Filed by: UBS Group AG -4.4%
2/7 Form SC 13G/A Evogene Ltd. Filed by: Senvest Management, LLC -3.6%
8/7 Form 6-K Evogene Ltd. For: Aug 07 -3.2%
7/11 Evogene Financial Results for the Second Quarter of 2019 Earnings Announcement Schedule -2.6%
11/18 Lavie Bio Announces Advancement in Its Product Development Pipeline for Wheat Bio-stimulants -2.3%
5/28 Q1/2019 3/31/2019 EPS -0.150 ZacksConsensus N/A ActVsEst N/A - N/A -1.7%
7/31 Q2/2019 6/30/2019 EPS -0.160 ZacksConsensus N/A ActVsEst N/A - N/A -5.4%
3/4 Q4/2019 12/31/2019 EPS -0.240 ZacksConsensus N/A ActVsEst N/A - N/A -5.2%
7/16 Evogene Amends its Collaboration Agreement With Bayer to Include Genome Editing Targets -5.1%
2/11 Form SC 13G/A Evogene Ltd. Filed by: UBS Group AG -4.4%
2/7 Form SC 13G/A Evogene Ltd. Filed by: Senvest Management, LLC -3.6%
8/7 Form 6-K Evogene Ltd. For: Aug 07 -3.2%
7/11 Evogene Financial Results for the Second Quarter of 2019 Earnings Announcement Schedule -2.6%
11/18 Lavie Bio Announces Advancement in Its Product Development Pipeline for Wheat Bio-stimulants -2.3%
5/28 Q1/2019 3/31/2019 EPS -0.150 ZacksConsensus N/A ActVsEst N/A - N/A -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: